Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.62 |
| ▸ | CA1 | P00915 | 4/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.56 |
| ▸ | CA12 | O43570 | 2/20 | 0.56 |
| ▸ | CA9 | Q16790 | 2/20 | 0.56 |
| ▸ | CA3 | P07451 | 1/20 | 0.56 |
| ▸ | CA6 | P23280 | 1/20 | 0.56 |
| ▸ | CA5A | P35218 | 1/20 | 0.56 |
| ▸ | CA7 | P43166 | 1/20 | 0.56 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.56 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | MMP1 | P03956 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | MMP9 | P14780 | 1/20 | 0.50 |
| ▸ | MMP8 | P22894 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3818642 | 0.97 | GAA (0.59) | GAACA1CA2CA12CA9 | |
| SCHEMBL338460 | 0.97 | GAA (0.59) | GAACA1CA2CA12CA9 | |
| SCHEMBL6551463 | 0.97 | GAA (0.59) | GAACA1CA2CA12CA9 | |
| Water SCHEMBL8615480 | 0.95 | GAA (0.56) | GAACA1CA2CA12CA9 | |
| Thiocyanic Acid SCHEMBL8512490 | 0.87 | GAA (0.48) | GAACA1CA2CA12CA9 | |
| SCHEMBL7949869 | 0.82 | GAA (0.43) | GAACA1CA2CA12CA9 | |
| SCHEMBL8038985 | 0.77 | GAA (0.68) | GAACA1CA2CA12CA9 | |
| P-Xylene SCHEMBL10728283 | 0.77 | GAA (0.52) | GAACA1CA2CA12CA9 | |
| SCHEMBL170033 | 0.77 | GAA (1.00) | GAACA1CA2CA12CA9 | |
| SCHEMBL4400955 | 0.77 | GAA (1.00) | GAACA1CA2CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 841 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250350072-A1 | IN-LINE FUSE FOR PHOTOVOLTAIC WIRING SYSTEMS | VOLTAGE LLC (US) | 2025-11-13 | — | — | US | claimed |
| WO-2025075413-A2 | SMART ROBOT HEALTH BIKE SYSTEM | 주식회사 운약근답 올핏 | 2025-04-10 | — | — | WO | claimed |
| US-20240299554-A1 | PRODRUGS WITH 1-(DISULFANYL)ALKYLOXY-CARBONYL UNITS | PHARMACYTICS B.V. (NL) | 2024-09-12 | — | — | US | claimed |
| CN-113906784-B | User Equipment (UE) measurement capability in high speed scenarios | 苹果公司 | 2024-08-30 | — | — | CN | claimed |
| EP-4359419-A1 | PRODRUGS WITH 1-(DISULFANYL)ALKYLOXY-CARBONYL UNITS | Pharmacytics B.V. (NL) | 2024-05-01 | — | — | EP | claimed |
| CN-115200170-B | Enthalpy injection control method and device for air conditioner and air conditioner | 宁波奥克斯电气股份有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-114963446-B | Control method and system for low-temperature enthalpy injection of multi-split air conditioner | 宁波奥克斯电气股份有限公司 | 2023-08-25 | — | — | CN | claimed |
| WO-2022271018-A1 | PRODRUGS WITH 1-(DISULFANYL)ALKYLOXY-CARBONYL UNITS | PHARMACYTICS B.V. (NL) | 2022-12-29 | — | — | WO | claimed |
| CN-115200170-A | Enthalpy spraying control method and device of air conditioner and air conditioner | 宁波奥克斯电气股份有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-114213948-A | Contains hollow SiO2@TiO2Preparation method of microsphere photocuring waterborne polyurethane heat-insulating coating | 江南大学 | 2022-03-22 | — | — | CN | claimed |
| US-20020151570-A1 | Thiosulfonic acid S-esters as agents for protecting material | BAYER AKTIENGESELLSCHAFT (DE) | 2002-10-17 | — | — | US | claimed |
| EP-0935597-A2 | DIHYDROPYRONES WITH IMPROVED ANTIVIRAL ACTIVITY | WARNER-LAMBERT COMPANY (US) | 1999-08-18 | — | — | EP | claimed |
| WO-1998019997-A2 | DIHYDROPYRONES WITH IMPROVED ANTIVIRAL ACTIVITY | WARNER-LAMBERT COMPANY (US) | 1998-05-14 | — | — | WO | claimed |
| US-5411855-A | Photographic element exhibiting improved speed and stability | EASTMAN KODAK COMPANY (US) | 1995-05-02 | — | — | US | claimed |
| US-5399479-A | A thisulfonic acid, a sulfinic acid and an alkynylamino-substi tuted benzoxazole or benzothiazole | EASTMAN KODAK COMPANY (US) | 1995-03-21 | — | — | US | claimed |
| EP-0122125-B1 | SILVER HALIDE EMULSION | KONICA CORPORATION (JP) | 1987-07-15 | — | — | EP | claimed |
| EP-0183673-A1 | Thiosulfonate derivatives, process for their preparation and pharmaceutical compositions containing them | SANOFI (FR) | 1986-06-04 | — | — | EP | claimed |
| EP-0182768-A1 | Pharmaceutical and veterinary compositions containing thiosulfonate derivatives | SANOFI (FR) | 1986-05-28 | — | — | EP | claimed |
| EP-0122125-A1 | Silver halide emulsion | KONICA CORPORATION (JP) | 1984-10-17 | — | — | EP | claimed |
| US-4086423-A | CEPHALOSPORINS, CYCLOADDITION OF GLYCINE DERIVATIVE TO THIAZINE COMPOUND | MERCK & CO., INC. (US) | 1978-04-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240299554-A1 | PRODRUGS WITH 1-(DISULFANYL)ALKYLOXY-CARBONYL UNITS | SI, SULT1E1, SULT1A1 | GAA 1651/4885CA1 140/4885CA2 110/4885 |
| US-20020151570-A1 | Thiosulfonic acid S-esters as agents for protecting material | TST, STS, SULT1E1 | GAA 1000/4885CA1 485/4885CA2 1857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.